Frederick, MD, December 14, 2017 --(PR.com
)-- Dr. Kpamegan brings more than 20 years of experience with a diverse technical background in pre-clinical and clinical statistics, as well as vaccine development. Dr. Kpamegan received a Ph.D. in Statistics from American University. He is also a recipient of a M.S. in Finance from George Washington University and has a Six Sigma Green Belt Certification and a Project Management Certificate from Lehigh University.
Dr. Kpamegan’s experience includes regulatory expertise in the development and use of biomarkers in the biotech industry and reviewing Phase I, Phase II, and Phase III vaccine protocols. Dr. Kpamegan has previously been with Novavax, Aeras Global TB Vaccines and Sanofi Pasteur. Dr. Kpamegan has broad and diverse technical background in clinical, pre-clinical, non-clinical biostatistics, oncology, and vaccine development. He Interacted with FDA/CBER in both clinical and nonclinical to defend clinical analysis and assay validation methods. His experience in clinical data management is a big asset to BioStat Solutions, Inc. Dr. Ena Bromley, President and Chief Scientific Officer states: “Eloi brings a wealth of experience to BSSI and we are excited to have him as Director of our Clinical Operations team.”
BioStat Solutions, Inc. (BSSI) is a privately held professional service corporation providing statistical and bioinformatics expertise to pharmaceutical and biotech companies as well as to the government and its contractors. BSSI’s diverse team of statisticians, bioinformaticists, epidemiologists and geneticists provides answers to complex and challenging analytical questions. Whether the client is facing big data or machine learning problems, or is looking for new biomarker or diagnostic device strategies, BSSI provides solid results towards effective decision-making. For more information, visit BSSI’s website at: http://www.biostatsolutions.com